Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (364)
  2. Journal Article (358)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (790)
  2. Department of Medicine (790)
  3. Gastrointestinal Oncology Service (790)
  4. Solid Tumor Oncology Division (790)
  5. Epidemiology and Biostatistics (178)
  6. Surgery (168)

More Groups

People
  1. Ghassan Abou-Alfa (156)
  2. Kenneth Yu (121)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (94)
  6. William Jarnagin (84)

More People

Years
  1. 2025 (38)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (294)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (308)
  2. Oxford University Press (71)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (790)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients
    Journal Article

    Yaeger, R.; Cercek, A.; O'Reilly, E. M.; Reidy, D. L.; Kemeny, N.; Wolinsky, T.; Capanu, M.; Gollub, M. J.; Rosen, N.; Berger, M. F.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer
    Journal Article

    Bendell, J.; O'Reilly, E. M.; Middleton, M. R.; Chau, I.; Hochster, H.; Fielding, A.; Burke, W.; Burris, H. 3rd
    Annals of Oncology (2015)

    Fulltext@MSK | Save
  • Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma
    Journal Article

    Li, D.; O'Reilly, E. M.
    Seminars in Oncology (2015)

    Fulltext@MSK | Save
  • Liver and bile duct cancer
    Book Section

    Abou-Alfa, G. K.; Jarnagin, W.; Lowery, M.; D'Angelica, M.; Brown, K.; Ludwig, E.; Covey, A.; Kemeny, N.; Goodman, K. A.; Shia, J.; more...
    In Niederhuber, J. E.; Armitage, J. O.; Doroshow, J. H.; Kastan, M. B.; Tepper, J. E. (Eds.) Abeloff's Clinical Oncology. 5th ed (2014)

    Fulltext@MSK | Save
  • FOLFIRINOX induction therapy for stage III pancreatic adenocarcinoma
    Meeting Abstract

    Sadot, E.; Doussot, A.; O'Reilly, E. M.; Gonen, M.; Kingham, T. P.; D'Angelica, M. I.; Fong, Y. M.; DeMatteo, R. P.; Jarnagin, W. R.; Allen, P. J.
    Journal of the American College of Surgeons (2014)

    Fulltext@MSK | Save
  • Pharmacogenomic modeling of pancreatic cancer (PDAC) for prediction of chemotherapy response and resistance in second-line treatment setting
    Meeting Abstract

    Yu, K. H.; Sangar, V.; Ricigliano, M.; Hidalgo, M.; O'Reilly, E. M.; Abou-Alfa, G. K.; Lowery, M. A.; Crotty, J. F.; Gary, K.; Cooper, B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • APACT: A phase 3 randomized, open-label, multicenter trial evaluating the use of adjuvant nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with surgically resected ductal pancreatic adenocarcinoma (PDA)
    Meeting Abstract

    Tempero, M. A.; Cardin, D. B.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Gemcitabine-related pnemonitis: Elucidation of risk factors
    Meeting Abstract

    Sahin, I. H.; Geyer, A.; Kelly, D.; O'Reilly, E. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Outcomes of biliary stents in advanced pancreatic cancer in the era of improved systemic therapy
    Meeting Abstract

    Park, W.; Mankal, P. K.; O'Reilly, E. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save